Unicycive TherapeuticsUNCY
13F holders, Q3 2025 (September 30)30holders +10
13new positions
3sold out
1famous investor
$4.36avg. 13F price*
At the end of Q3 2025, 30 institutions reported holding Unicycive Therapeutics Inc. (UNCY) in their 13F filings, up 10 from Q2 2025. 13 opened new positions and 3 sold out. The largest holders were Vivo Capital, LLC ($7.8M), Octagon Capital Advisors LP ($4.4M) and Nantahala Capital Management, LLC ($4.1M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Unicycive Therapeutics Inc.
- CUSIP
- 90466Y202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $1.5M |
| Exits | 3 | $215K |
All 13F filers, Q2 2025 → Q3 2025: 1,189,752 shares bought and 47,988 shares sold, net +1,141,764 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Vivo Capital, LLC | 0.63% | Add +57.4% | 1,789,916 | $7.8M |
| Octagon Capital Advisors LP | 0.68% | No change | 1,000,000 | $4.4M |
| Nantahala Capital Management, LLC | 0.25% | No change | 939,202 | $4.1M |
| Great Point Partners LLC | 1.45% | No change | 796,558 | $3.5M |
| Vanguard Group Inc. | 0.00% | Add +8.7% | 658,878 | $2.9M |
| Logos Global Management LP | 0.20% | Add +0.0% | 473,563 | $2.1M |
| Geode Capital Management, LLC | 0.00% | Add +113.9% | 125,727 | $548K |
| Squarepoint Ops LLC | 0.00% | New | 117,327 | $512K |
| Acuta Capital Partners, LLC | 0.27% | Reduce -4.6% | 59,985 | $262K |
| State Street Corp. | 0.00% | Add +337.8% | 54,827 | $239K |
| Goldman Sachs Group Inc. | 0.00% | New | 45,200 | $197K |
| Citadel Advisors | 0.00% | New | 41,674 | $182K |
| XTX Topco Ltd | 0.01% | New | 37,823 | $165K |
| BlackRock, Inc. | 0.00% | New | 36,355 | $159K |
| Northern Trust Corp. | 0.00% | Add +203.1% | 32,699 | $143K |
| Chicago Partners Investment Group LLC | 0.00% | New | 26,961 | $127K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 23,947 | $104K |
| Morgan Stanley | 0.00% | Add +961.2% | 10,612 | $46K |
| Citigroup Inc. | 0.00% | New | 6,692 | $29K |
| UBS Group AG | 0.00% | New | 5,445 | $24K |
| Bank of America Corp. | 0.00% | Add +1192.2% | 827 | $4K |
| SBI Securities Co., Ltd. | 0.00% | Add +1.3% | 560 | $2K |
| Rockefeller Capital Management L.P. | 0.00% | New | 500 | $2K |
| TFC Financial Management, Inc. | 0.00% | New | 300 | $1K |
| Fortitude Family Office, LLC | 0.00% | New | 107 | $467 |
| Harbour Investments, Inc. | 0.00% | No change | 100 | $436 |
| Barclays PLC | 0.00% | No change | 80 | $349 |
| BNP Paribas Financial Markets | 0.00% | New | 55 | $240 |
| Bogart Wealth, LLC | 0.00% | No change | 6 | $26 |
| Danske Bank A/S | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is UNCY's weight in each manager's 13F, not the share of Unicycive Therapeutics Inc. the manager owns.